Search Patents
  • PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES
    Publication number: 20140343136
    Abstract: The present invention relates to one or more of the phytocannabinoids tetrahydrocannabivarin (THCV); cannabigerol (CBG); cannabichromene (CBC); and cannabidivarin (CBDV) for use in the treatment of intestinal inflammatory diseases. Preferably the intestinal inflammatory disease is either ulcerative colitis or Crohn's disease.
    Type: Application
    Filed: November 21, 2012
    Publication date: November 20, 2014
    Inventors: Angelo Antonio Izzo, Francesca Borelli, Stephen Wright
  • METHODS AND SYSTEMS FOR MANAGING VAPOR DISTRIBUTION
    Publication number: 20190380382
    Abstract: Provided are systems, methods, and vapor devices for providing customized vapor to a user. A customized vapor may ensure a particular flavor and/or chemical (e.g., nicotine, tetrahydrocannabinol, cannabidiol, cannabinol, cannabigerol, etc.) concentration of a vapor, or assist to reduce and/or eliminate substance dependency of a user, such as a nicotine or a cannabis dependency.
    Type: Application
    Filed: August 12, 2019
    Publication date: December 19, 2019
    Inventors: Charles Hassan, Marcus Shotey
  • Composition and Method for Treating Chronic Pain
    Publication number: 20230218566
    Abstract: The invention relates to pharmaceutical compositions comprising ?9-tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabigerol (CBG) and a terpene component, and their use in the treatment of chronic pain. The invention also relates to methods for treating chronic pain, especially chronic pain in athletes.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 13, 2023
    Inventors: Richard HOPKINS, Meghan Gail THOMAS, Oludare ODUMOSU
  • Methods and Systems for Managing Vapor Distribution
    Publication number: 20190380381
    Abstract: Provided are systems, methods, and vapor devices for providing customized vapor to a user. A customized vapor may ensure a particular flavor and/or chemical (e.g., nicotine, tetrahydrocannabinol, cannabidiol, cannabinol, cannabigerol, etc.) concentration of a vapor, or assist to reduce and/or eliminate substance dependency of a user, such as a nicotine or a cannabis dependency.
    Type: Application
    Filed: June 18, 2019
    Publication date: December 19, 2019
    Inventors: Charles Hassan, Marcus Shotey
  • Phytocannabinoids for use in the treatment of intestinal inflammatory diseases
    Patent number: 9421187
    Abstract: The present invention relates to one or more of the phytocannabinoids tetrahydrocannabivarin (THCV); cannabigerol (CBG); cannabichromene (CBC); and cannabidivarin (CBDV) for use in the treatment of intestinal inflammatory diseases. Preferably the intestinal inflammatory disease is either ulcerative colitis or Crohn's disease.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: August 23, 2016
    Assignee: GW Pharma Limited
    Inventors: Angelo Antonio Izzo, Francesca Borrelli, Stephen Wright
  • CIGARETTE ADHESIVE INCLUDING MEDICINAL OR RECREATIONAL SUBSTANCES
    Publication number: 20210259302
    Abstract: A smoking article, such as a cigarette or cigar, having an outer layer and a combustible substance disposed within the outer layer. An adhesive is applied to at least a portion of the outer layer around the combustible substance to create a rolled smoking article. The adhesive includes a predetermined dosage of a cannabinoid, such as, but not limited to, phytocannabinoid thetrahydrocannabinol, cannabidiol, and cannabigerol.
    Type: Application
    Filed: April 27, 2020
    Publication date: August 26, 2021
    Inventors: Kelly Ritter, III, Andrew Neil Blay
  • ORAL CARE COMPOSITION COMPRISING CANNABINOIDS
    Publication number: 20160166498
    Abstract: This application discloses oral care compositions comprising cannabinoids, preferably cannabidiol and/or cannabigerol. The oral care composition disclosed in this application may be a tooth paste, a tooth powder, or a mouthwash solution. The oral care composition may be used to treat oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain.
    Type: Application
    Filed: December 15, 2015
    Publication date: June 16, 2016
    Inventors: George ANASTASSOV, Lekhram CHANGOER
  • ORAL CARE COMPOSITION COMPRISING CANNABINOIDS
    Publication number: 20190076349
    Abstract: This application discloses oral care compositions comprising cannabinoids, preferably cannabidiol and/or cannabigerol. The oral care composition disclosed in this application may be a tooth paste, a tooth powder, or a mouthwash solution. The oral care composition may be used to treat oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Inventors: George ANASTASSOV, Lekhram CHANGOER
  • ORAL CARE COMPOSITION COMPRISING CANNABINOIDS
    Publication number: 20200330339
    Abstract: This application discloses oral care compositions comprising cannabinoids, preferably cannabidiol and/or cannabigerol. The oral care composition disclosed in this application may be a tooth paste, a tooth powder, or a mouthwash solution. The oral care composition may be used to treat oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain.
    Type: Application
    Filed: July 2, 2020
    Publication date: October 22, 2020
    Inventors: George ANASTASSOV, Lekhram CHANGOER
  • COMPOSITIONS AND METHODS FOR PROMOTING SLEEP
    Publication number: 20230330057
    Abstract: A composition for promoting sleep includes a mixture of cannabinoids and a carrier. The mixture of cannabinoids includes cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN). The composition may further include one or more supplemental active ingredients. The one or more supplemental active ingredients may include L-theanine, GABA, 5-HTP and/or melatonin.
    Type: Application
    Filed: April 15, 2022
    Publication date: October 19, 2023
    Inventor: Jacob Chavez
  • A CANNABINOID MIXTURE
    Publication number: 20240122947
    Abstract: There is disclosed a composition comprising cannabidiol (CBD) and one or more cannabinoids selected from cannabidiolic acid (CBDA), cannabigerol (CBG) and cannabigerolic acid (CBGA) for use in the treatment or prevention of inflammation and disorders associated with inflammation or an IL-6 related disorder.
    Type: Application
    Filed: February 8, 2022
    Publication date: April 18, 2024
    Applicants: TTS Pharma Ltd, Aberystwyth University
    Inventors: Robert WALTON, Mark TUCKER, Debbie NASH, Nathan ALLEN, Ruth WONFOR, Ifat SHAH
  • METHODS TO REFINE CANNABINOIDS
    Publication number: 20230101492
    Abstract: This disclosure generally relates to gas-phase methods to simultaneously purify and decarboxylate cannabinoids in about two seconds, which are about 100-10,000 times more efficient than conventional purification and decarboxylation strategies. The methods also recover thermolabile cannabinoids such as cannabigerol at significantly higher yields than conventional methods.
    Type: Application
    Filed: February 6, 2021
    Publication date: March 30, 2023
    Applicant: NATURAL EXTRACTION SYSTEMS, LLC
    Inventor: C. Russell THOMAS
  • METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL RESPIRATORY INFECTIONS
    Publication number: 20230330037
    Abstract: A method of treating or preventing respiratory viral infections. The method includes administering to a patient a pharmaceutical composition comprising one or more non psychoactive cannabinoid-containing compositions consisting essentially of a cannabinoid fraction including at least one of Cannabigerol (CBG) or Cannabigerolic acid (CBGA) and a non-cannabinoid fraction from Cannabis sativa L., turmeric, and black pepper and other plant sources.
    Type: Application
    Filed: April 14, 2022
    Publication date: October 19, 2023
    Inventor: V. Hari
  • Cannabinoids for use in the treatment of neuropathic pain
    Patent number: 9895342
    Abstract: The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV) or tetrahydrocannabivarin (THCV). More preferably the phytocannabinoids are isolated and/or purified from cannabis plant extracts.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: February 20, 2018
    Assignee: GW Pharma Limited
    Inventors: Sabatino Maione, Francesco Rossi, Geoffrey Guy, Colin Stott, Tetsuro Kikuchi
  • METHODS OF USE FOR OENOTHEIN A AND B FROM EPILOBIUM SPECIES
    Publication number: 20200179426
    Abstract: The invention provides medicaments comprising an oenothein, including oral formulations to treat inflammation or to treat hormone balance in perimenopausal, menopausal and postmenopausal women. The oenothein for use in such formulations, such as oenothein A and oenothein B, maybe purified from natural sources, such as Epilobium, and used in combination with a cannabinoid, such as cannabidiol (CBD), cannabigerol (CBG) or tetrahydrocannabinol (THC).
    Type: Application
    Filed: February 11, 2020
    Publication date: June 11, 2020
    Inventor: Robert Jacquet
  • CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
    Publication number: 20140378539
    Abstract: The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV) or tetrahydrocannabivarin (THCV). More preferably the phytocannabinoids are isolated and/or purified from cannabis plant extracts.
    Type: Application
    Filed: May 18, 2012
    Publication date: December 25, 2014
    Applicants: Otsuka Pharmaceutical Co., Limited, GW Pharma Limited
    Inventors: Sabatino Maione, Francesco Rossi, Geoffrey Guy, Colin Stott, Tetsuro Kikuchi
  • CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
    Publication number: 20140107192
    Abstract: The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV) or tetrahydrocannabivarin (THCV). More preferably the phytocannabinoids are isolated and/or purified from cannabis plant extracts.
    Type: Application
    Filed: May 18, 2012
    Publication date: April 17, 2014
    Applicants: Otsuka Pharmaceutical Co., Limited, GW Pharma Limited
    Inventors: Sabatino Maione, Francesco Rossi, Geoffrey Guy, Colin Stott, Tetsuro Kikuchi
  • PSILOCYBIN AND/OR PSILOCIN IN COMBINATION WITH CANNABINOIDS AND/OR TERPENES
    Publication number: 20190350949
    Abstract: One or more cannabinoids and/or terpenes in combination with psilocybin and/or psilocin may be used in the prevention or treatment of psychological or brain disorders. The one or more cannabinoids may be taken from the group of cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA).
    Type: Application
    Filed: January 18, 2018
    Publication date: November 21, 2019
    Inventors: Murat Küçüksen, Ali Neset Küçüksen
  • BREWING SUBSTANCE CONTAINER FOR USE IN BREWING MACHINE
    Publication number: 20200390267
    Abstract: Disclosed is a container for a brewing substance, where the container comprises a housing having an interior; a brewing substance located in the interior of the housing; and a non-liquid substance comprising at least one cannabinoid, such as cannabidiol (CBD), cannabigerol (CBG), and/or cannabinol (CBN). In one embodiment, a filter contains the brewing substance in the housing and the non-liquid substance is located below the filter. Also disclosed are methods of assembling the container.
    Type: Application
    Filed: June 16, 2020
    Publication date: December 17, 2020
    Applicant: Life's a Venture, LLC
    Inventors: Baxter Cook, Cheery Furr
  • Oral care composition comprising cannabinoids
    Patent number: 11890361
    Abstract: This application discloses oral care compositions comprising cannabinoids, preferably cannabidiol and/or cannabigerol. The oral care composition disclosed in this application may be a tooth paste, a tooth powder, or a mouthwash solution. The oral care composition may be used to treat oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: February 6, 2024
    Assignee: APIRx Pharmaceutical USA, LLC
    Inventors: George Anastassov, Lekhram Changoer
Narrow Results

Filter by US Classification